Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Distance | 1 | 2020 | 93 | 0.690 |
Why?
|
| Echocardiography | 2 | 2020 | 1182 | 0.610 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 46 | 0.540 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 180 | 0.500 |
Why?
|
| Cardiology | 1 | 2020 | 530 | 0.500 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 603 | 0.440 |
Why?
|
| Clinical Competence | 1 | 2020 | 1270 | 0.430 |
Why?
|
| Child Mortality | 1 | 2012 | 21 | 0.430 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 687 | 0.410 |
Why?
|
| Recovery of Function | 1 | 2015 | 703 | 0.410 |
Why?
|
| Heart Ventricles | 2 | 2018 | 846 | 0.400 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2009 | 1586 | 0.390 |
Why?
|
| Aortic Valve Stenosis | 1 | 2015 | 476 | 0.360 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2023 | 136 | 0.360 |
Why?
|
| Immunization, Secondary | 2 | 2009 | 110 | 0.350 |
Why?
|
| Vaccinia virus | 1 | 2009 | 79 | 0.340 |
Why?
|
| Smallpox Vaccine | 1 | 2009 | 43 | 0.340 |
Why?
|
| Arterial Switch Operation | 2 | 2018 | 19 | 0.320 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2009 | 221 | 0.300 |
Why?
|
| Melanoma, Experimental | 1 | 2009 | 368 | 0.290 |
Why?
|
| HIV | 1 | 2008 | 229 | 0.280 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 582 | 0.270 |
Why?
|
| Heart Diseases | 1 | 2012 | 732 | 0.270 |
Why?
|
| Interferon-gamma | 2 | 2009 | 1144 | 0.270 |
Why?
|
| Hepacivirus | 1 | 2008 | 397 | 0.250 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 1033 | 0.240 |
Why?
|
| Cancer Vaccines | 1 | 2009 | 697 | 0.230 |
Why?
|
| Peptides | 1 | 2009 | 1479 | 0.230 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 44 | 0.220 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1237 | 0.220 |
Why?
|
| Hepatitis C | 1 | 2008 | 524 | 0.210 |
Why?
|
| Biliary Atresia | 1 | 2023 | 191 | 0.190 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2018 | 18 | 0.160 |
Why?
|
| HIV Infections | 2 | 2008 | 2134 | 0.160 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2018 | 71 | 0.160 |
Why?
|
| Stroke Volume | 2 | 2023 | 577 | 0.160 |
Why?
|
| Child | 8 | 2023 | 29154 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 610 | 0.150 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 3869 | 0.150 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2021 | 300 | 0.140 |
Why?
|
| Purines | 1 | 2018 | 273 | 0.140 |
Why?
|
| Curriculum | 1 | 2020 | 860 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 1011 | 0.110 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2012 | 21 | 0.110 |
Why?
|
| Boston | 1 | 2012 | 108 | 0.110 |
Why?
|
| ROC Curve | 1 | 2015 | 1183 | 0.110 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2012 | 31 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2018 | 16273 | 0.100 |
Why?
|
| Infant | 3 | 2018 | 13310 | 0.090 |
Why?
|
| Young Adult | 4 | 2021 | 21445 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2020 | 1375 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2018 | 1471 | 0.090 |
Why?
|
| Cause of Death | 1 | 2012 | 752 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 7702 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1697 | 0.080 |
Why?
|
| Vaccines, Subunit | 1 | 2009 | 124 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 235 | 0.080 |
Why?
|
| Species Specificity | 1 | 2009 | 777 | 0.080 |
Why?
|
| Adolescent | 4 | 2018 | 31252 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 1489 | 0.070 |
Why?
|
| Female | 7 | 2023 | 141928 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2009 | 374 | 0.070 |
Why?
|
| Transposition of Great Vessels | 2 | 2018 | 124 | 0.070 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 446 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 462 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2012 | 1274 | 0.070 |
Why?
|
| Humans | 11 | 2023 | 261506 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2020 | 12873 | 0.070 |
Why?
|
| Comorbidity | 1 | 2012 | 2352 | 0.070 |
Why?
|
| Aorta | 2 | 2021 | 692 | 0.070 |
Why?
|
| Adult | 5 | 2021 | 77950 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2018 | 37905 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2009 | 1869 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 2314 | 0.060 |
Why?
|
| Immunization | 1 | 2005 | 397 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2018 | 8223 | 0.060 |
Why?
|
| Male | 6 | 2023 | 123000 | 0.060 |
Why?
|
| Vaccination | 1 | 2009 | 1123 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 5377 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2005 | 842 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 321 | 0.050 |
Why?
|
| Dobutamine | 1 | 2021 | 54 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 246 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 14889 | 0.050 |
Why?
|
| Cytokines | 1 | 2009 | 2809 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 6942 | 0.040 |
Why?
|
| Heart Failure | 1 | 2012 | 2516 | 0.040 |
Why?
|
| Time Factors | 1 | 2012 | 12926 | 0.040 |
Why?
|
| Heart Valves | 1 | 2018 | 66 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 941 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 665 | 0.030 |
Why?
|
| Risk Factors | 1 | 2012 | 17523 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 737 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 502 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2023 | 4892 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 499 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 14551 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2018 | 935 | 0.030 |
Why?
|
| Middle Aged | 2 | 2012 | 86204 | 0.030 |
Why?
|
| Heart | 1 | 2018 | 1223 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 32848 | 0.020 |
Why?
|
| Mice | 1 | 2009 | 34495 | 0.020 |
Why?
|
| Aged | 1 | 2012 | 70117 | 0.020 |
Why?
|
| Hepatitis A Antigens | 1 | 2005 | 2 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2005 | 20 | 0.020 |
Why?
|
| Hepatitis A | 1 | 2005 | 32 | 0.020 |
Why?
|
| Tetanus Toxin | 1 | 2005 | 38 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 2005 | 78 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2005 | 334 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2005 | 284 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2005 | 383 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2005 | 257 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2005 | 250 | 0.020 |
Why?
|
| Animals | 1 | 2009 | 59536 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 317 | 0.010 |
Why?
|
| Hepatitis B | 1 | 2005 | 258 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2005 | 709 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2005 | 1294 | 0.010 |
Why?
|